Analysis of incidence and prognostic significance <i>FLT3, c-KIT</i> and <i>NPM1</i> genes mutation in children with acute myeloid leukemia

Prognosis of patients with acute myeloid leukemia receiving intensive chemotherapy is defined as kariotyping anomalies, and mutations of genes responsible for surviving and self-maintenance leukemic cells. In the giving work incidence of mutation involving genes FLT3, c-KIT, NPM1 having prognostic v...

Full description

Bibliographic Details
Main Authors: L. V. Guk, T. V. Savitskaya, D. A. Domninsky, V. O. Bobrinina, M. M. Schneider, A. A. Maschan, O. V. Aleinikova
Format: Article
Language:Russian
Published: ABV-press 2022-11-01
Series:Онкогематология
Subjects:
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/783
_version_ 1797855457336885248
author L. V. Guk
T. V. Savitskaya
D. A. Domninsky
V. O. Bobrinina
M. M. Schneider
A. A. Maschan
O. V. Aleinikova
author_facet L. V. Guk
T. V. Savitskaya
D. A. Domninsky
V. O. Bobrinina
M. M. Schneider
A. A. Maschan
O. V. Aleinikova
author_sort L. V. Guk
collection DOAJ
description Prognosis of patients with acute myeloid leukemia receiving intensive chemotherapy is defined as kariotyping anomalies, and mutations of genes responsible for surviving and self-maintenance leukemic cells. In the giving work incidence of mutation involving genes FLT3, c-KIT, NPM1 having prognostic value in adults is analysed. Kynase domain FLT3 mutation in 18 from 83 patients (21.6%) was detected. 2 from 18 patients (11%) achieved complete remission, 5 from 18 patients (27.7%) with FLT3 mutations were refractory to therapy, two patients died from treatment complications, 9 from 18 (50%) relapsed. Only 2 patients (11%) are alive in continuous complete remission. с-KIT mutations detected in 14.2% (2/14 patients), and NPM1 mutations represented allelic polymorphism. Thus, kynase domain FLT3 mutation are prognostic unfavorable.
first_indexed 2024-04-09T20:22:57Z
format Article
id doaj.art-38efe043a43a4d2aa46c334aadeaad03
institution Directory Open Access Journal
issn 1818-8346
2413-4023
language Russian
last_indexed 2024-04-09T20:22:57Z
publishDate 2022-11-01
publisher ABV-press
record_format Article
series Онкогематология
spelling doaj.art-38efe043a43a4d2aa46c334aadeaad032023-03-30T20:15:16ZrusABV-pressОнкогематология1818-83462413-40232022-11-0104273210.17650/1818-8346-2009-0-4-27-32661Analysis of incidence and prognostic significance <i>FLT3, c-KIT</i> and <i>NPM1</i> genes mutation in children with acute myeloid leukemiaL. V. Guk0T. V. Savitskaya1D. A. Domninsky2V. O. Bobrinina3M. M. Schneider4A. A. Maschan5O. V. Aleinikova6Federal research center of pediatric hematology, oncology and immunologyRepublic Centre for Paediatric Oncology and HaematologyFederal research center of pediatric hematology, oncology and immunologyFederal research center of pediatric hematology, oncology and immunologyFederal research center of pediatric hematology, oncology and immunologyFederal research center of pediatric hematology, oncology and immunologyRepublic Centre for Paediatric Oncology and HaematologyPrognosis of patients with acute myeloid leukemia receiving intensive chemotherapy is defined as kariotyping anomalies, and mutations of genes responsible for surviving and self-maintenance leukemic cells. In the giving work incidence of mutation involving genes FLT3, c-KIT, NPM1 having prognostic value in adults is analysed. Kynase domain FLT3 mutation in 18 from 83 patients (21.6%) was detected. 2 from 18 patients (11%) achieved complete remission, 5 from 18 patients (27.7%) with FLT3 mutations were refractory to therapy, two patients died from treatment complications, 9 from 18 (50%) relapsed. Only 2 patients (11%) are alive in continuous complete remission. с-KIT mutations detected in 14.2% (2/14 patients), and NPM1 mutations represented allelic polymorphism. Thus, kynase domain FLT3 mutation are prognostic unfavorable.https://oncohematology.abvpress.ru/ongm/article/view/783acute myeloid leukemiachildren<i>flt3c-kitnpm1</i> genes
spellingShingle L. V. Guk
T. V. Savitskaya
D. A. Domninsky
V. O. Bobrinina
M. M. Schneider
A. A. Maschan
O. V. Aleinikova
Analysis of incidence and prognostic significance <i>FLT3, c-KIT</i> and <i>NPM1</i> genes mutation in children with acute myeloid leukemia
Онкогематология
acute myeloid leukemia
children
<i>flt3
c-kit
npm1</i> genes
title Analysis of incidence and prognostic significance <i>FLT3, c-KIT</i> and <i>NPM1</i> genes mutation in children with acute myeloid leukemia
title_full Analysis of incidence and prognostic significance <i>FLT3, c-KIT</i> and <i>NPM1</i> genes mutation in children with acute myeloid leukemia
title_fullStr Analysis of incidence and prognostic significance <i>FLT3, c-KIT</i> and <i>NPM1</i> genes mutation in children with acute myeloid leukemia
title_full_unstemmed Analysis of incidence and prognostic significance <i>FLT3, c-KIT</i> and <i>NPM1</i> genes mutation in children with acute myeloid leukemia
title_short Analysis of incidence and prognostic significance <i>FLT3, c-KIT</i> and <i>NPM1</i> genes mutation in children with acute myeloid leukemia
title_sort analysis of incidence and prognostic significance i flt3 c kit i and i npm1 i genes mutation in children with acute myeloid leukemia
topic acute myeloid leukemia
children
<i>flt3
c-kit
npm1</i> genes
url https://oncohematology.abvpress.ru/ongm/article/view/783
work_keys_str_mv AT lvguk analysisofincidenceandprognosticsignificanceiflt3ckitiandinpm1igenesmutationinchildrenwithacutemyeloidleukemia
AT tvsavitskaya analysisofincidenceandprognosticsignificanceiflt3ckitiandinpm1igenesmutationinchildrenwithacutemyeloidleukemia
AT dadomninsky analysisofincidenceandprognosticsignificanceiflt3ckitiandinpm1igenesmutationinchildrenwithacutemyeloidleukemia
AT vobobrinina analysisofincidenceandprognosticsignificanceiflt3ckitiandinpm1igenesmutationinchildrenwithacutemyeloidleukemia
AT mmschneider analysisofincidenceandprognosticsignificanceiflt3ckitiandinpm1igenesmutationinchildrenwithacutemyeloidleukemia
AT aamaschan analysisofincidenceandprognosticsignificanceiflt3ckitiandinpm1igenesmutationinchildrenwithacutemyeloidleukemia
AT ovaleinikova analysisofincidenceandprognosticsignificanceiflt3ckitiandinpm1igenesmutationinchildrenwithacutemyeloidleukemia